Cell Therapy Development Support
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
49
NCT04121468
A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With Multiple Sclerosis
Phase: Phase 1/2
Role: Collaborator
Start: Feb 24, 2020
Completion: Oct 31, 2027
NCT05344521
A Phase I, Single-blind, Randomized Study of the Safety and Efficacy of Cellularized Integra® Using Autologous Burn-derived Stem Cells
Phase: Phase 1
Start: Feb 29, 2024
Completion: Feb 28, 2027
Loading map...